About Element Biosciences
Element Biosciences is a company based in Sunnyvale (United States) founded in 2015 was acquired by Element Biosciences in February 2022. It operates as a Product-as-a-Service and Direct-to-Consumer (D2C). Element Biosciences has raised $8.12 million across 3 funding rounds from investors including Element Biosciences, Khosla Ventures and Wilson Sonsini Goodrich & Rosati. Element Biosciences offers products and services including AVITI24, Cloudbreak Sequencing Kits, and ElemBio Cloud. Element Biosciences operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Element Biosciences
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.12 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Series A
Nov 01, 2018
-
Investors
Element Biosciences
& 6 more
-
Employee Count
Not available
-
Acquired by
Element Biosciences
(Feb 08, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Element Biosciences
Element Biosciences offers a comprehensive portfolio of products and services, including AVITI24, Cloudbreak Sequencing Kits, and ElemBio Cloud.
Advanced system for 5D multiomics biological analysis.
Kits designed for high-quality sequencing applications.
Platform for managing and analyzing sequencing data.
People of Element Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Element Biosciences
Element Biosciences has successfully raised a total of $8.12M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Element Biosciences
Element Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Element Biosciences, Khosla Ventures and Wilson Sonsini Goodrich & Rosati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Investment in early-stage startups focusing on healthcare, AI, and industrial technology.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on software, fintech, marketplaces, and consumer internet
|
Locked | Locked | Locked |
Investor details for Element Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Element Biosciences
Investment portfolio details for Element Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Element Biosciences
Detailed financials for Element Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Element Biosciences Comparisons
Peer comparison for Element Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Element Biosciences
Element Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
Detailed competitors of Element Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Element Biosciences
Complete news archive for Element Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Element Biosciences
Element Biosciences was founded in 2015.
Element Biosciences is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Element Biosciences is a funded company, having raised a total of $8.12M across 3 funding rounds to date.
Element Biosciences is engaged in developing innovative genomic sequencing solutions. The company operates within the biotechnology sector, offering instruments, reagents, kits, and software for multiomics research. Products like AVITI24 enable spatial and single-cell co-detection of RNA, protein, and morphology. Their technology supports applications in DNA and RNA sequencing, long-read sequencing, and focus areas such as agricultural biology and pharmaceuticals. Solutions are designed to provide high-quality, affordable sequencing for scientific communities.
Element Biosciences offers AVITI24, Cloudbreak Sequencing Kits, and ElemBio Cloud.
Element Biosciences has 7 investors. Key investors include Element Biosciences, Khosla Ventures, Wilson Sonsini Goodrich & Rosati, Fusion Fund, and DN Capital.